Publications
454
Citations
21,735
Est. group size
~4
Recurring co-author estimate
Active years
44
Publishing since 1983
Octavio Ramilo's research focuses on infectious diseases in infants and children, particularly respiratory syncytial virus (RSV, a common cause of severe respiratory illness in babies), bacterial infections in febrile infants, and childhood pneumonia. His recent work includes large clinical trials of new antibody treatments to prevent RSV disease, as well as studies using biomarkers and gene-expression signatures to better diagnose infections in young children. This research is aimed at improving early detection and prevention of serious infections in newborns and young infants.
Publication output has remained fairly steady over the past decade, with a peak around 2019-2021, a decline through 2022-2023, and a recent rebound in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Clesrovimab for Prevention of RSV Disease in Healthy Infants
New England Journal of Medicine · 2025
- 166. A Phase 2b/3 Study to Evaluate the Efficacy and Safety of an Investigational Respiratory Syncytial Virus (RSV) Antibody, Clesrovimab, in Healthy Preterm and Full-Term Infants
Open Forum Infectious Diseases · 2025
- Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease
New England Journal of Medicine · 2025
- Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials
Contemporary Clinical Trials · 2025
- 167. Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease
Open Forum Infectious Diseases · 2025
- Metagenomic signatures of extraintestinal bacterial infection in the febrile term infant gut microbiome
Microbiome · 2025
- Improvement in Palivizumab Administration in Severely Immunocompromised Children: A Single-institution Quality Improvement Initiative
Pediatric Quality and Safety · 2025
- Transcriptomic Biomarkers Associated With Microbiological Etiology and Disease Severity in Childhood Pneumonia
The Journal of Infectious Diseases · 2024
- Leukopenia, neutropenia, and procalcitonin levels in young febrile infants with invasive bacterial infections
Academic Emergency Medicine · 2024
- Correlation between locally versus centrally processed serum procalcitonin during emergency department research evaluation of febrile infants aged 0–60 days
Practical Laboratory Medicine · 2024
- SARS-CoV-2 infection vs. vaccination during pregnancy: the placenta leads the way
Current Opinion in Infectious Diseases · 2024
- Risk of recurrent cefepime-resistant bacterial infection during febrile neutropenia in pediatric oncology and hematopoietic cell transplantation
Journal of the Pediatric Infectious Diseases Society · 2024
- Are the first 1,000 days of life a neglected vital period to prevent the impact on maternal and infant morbimortality of infectious diseases in Latin America? Proceedings of a workshop of experts from the Latin American Pediatric Infectious Diseases Society, SLIPE
Frontiers in Pediatrics · 2023
- Radiographic pneumonia in young febrile infants presenting to the emergency department: secondary analysis of a prospective cohort study
Emergency Medicine Journal · 2023
- Serious Bacterial Infections in Young Febrile Infants With Positive Urinalysis Results
PEDIATRICS · 2022
- Open Forum Infectious Diseases×37
- The Journal of Infectious Diseases×16
- PEDIATRICS×14
- The Pediatric Infectious Disease Journal×14
- The Journal of Pediatrics×9
- Asunción Mejías
Medicine · The Ohio State University
- Mark E. Peeples
Medicine · The Ohio State University
- Jacqueline Corry
Medicine · The Ohio State University
- Phylip Chen
Medicine · The Ohio State University
- Syed-Rehan A. Hussain
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile